glp-1 impact on alcohol consumption A preliminary study of the physiological and perceptual effects of receptor agonists during in people with obesity GLP-1s Hold Promise as Treatment
Description
It needs to be administered with care though Two years ago, Chirag Shah thought the only solution to his problem was surgery
However, clinical trials investigating GLP-1RAs in diseases such as AD, PD, mild cognitive impairment, psychiatric disorders, and diabetes have yielded mixed results for cognitive and motor function
10.1038/s41573-021-00337-8
(3) insufficient sample size in some subgroups (e.g., 54 cases in the 360 days
95% CI: 0.620.88)
